quinoxalines has been researched along with Emesis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrios, M; Cicero, A; Cristóbal, M; Jiménez-Ruiz, CA; Mayayo, M; Peña, S; Perera, L | 1 |
| Faessel, HM; Rollema, H; Williams, KE | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Gibbs, MA; Rohrbacher, K; Stolar, M | 1 |
| Dodds, WJ; Lang, IM; Sarna, SK | 1 |
| Fukuda, H; Furukawa, N; Hatano, M; Koga, T | 1 |
| Lang, IM; Sarna, SK; Shaker, R | 1 |
| Fukuda, H; Furukawa, N; Hatano, M | 1 |
| Fink-Jensen, A; Hansen, JB; Honoré, T; Jacobsen, P; Judge, ME; Olney, J; Turski, L | 1 |
| Clark, GM; Coltman, CA; Hersh, M; Kuhn, JG; Melink, T; Von Hoff, DD; Weiss, GR | 1 |
1 trial(s) available for quinoxalines and Emesis
| Article | Year |
|---|---|
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzazepines; Cotinine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Half-Life; Headache; Humans; Hypotension, Orthostatic; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Nicotine; Patient Dropouts; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Varenicline; Vomiting | 2006 |
8 other study(ies) available for quinoxalines and Emesis
| Article | Year |
|---|---|
Increasing the dose of varenicline in patients who do not respond to the standard dose.
Topics: Adult; Aged; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Records; Middle Aged; Nausea; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Vomiting | 2013 |
Varenicline overdose in a teenager--a clinical pharmacology perspective.
Topics: Adolescent; Benzazepines; Drug Overdose; Humans; Nausea; Poisoning; Quinoxalines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Serotonin Receptor Agonists; Varenicline; Vomiting | 2009 |
Pharyngeal, esophageal, and proximal gastric responses associated with vomiting.
Topics: Adrenergic alpha-Agonists; Animals; Apomorphine; Brimonidine Tartrate; Dogs; Electromyography; Esophagus; Female; Intestine, Small; Male; Models, Biological; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Nerve Block; Pharynx; Quinoxalines; Stomach; Vagus Nerve; Vomiting | 1993 |
Non-N-methyl-D-aspartate receptors may mediate the transmission of emetic signals between visceral vagal afferents and the solitary nucleus in dogs.
Topics: Anesthesia; Animals; Decerebrate State; Dizocilpine Maleate; Dogs; Electric Stimulation; Excitatory Amino Acid Antagonists; Lingual Nerve; Phrenic Nerve; Quinoxalines; Reaction Time; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Salivation; Solitary Nucleus; Synaptic Transmission; Vagus Nerve; Vomiting | 1998 |
Gastrointestinal motor and myoelectric correlates of motion sickness.
Topics: Animals; Atropine Derivatives; Brimonidine Tartrate; Cats; Copper Sulfate; Digestive System; Female; Gastrointestinal Motility; Male; Motion Sickness; Myoelectric Complex, Migrating; Quinoxalines; Salivation; Vagotomy; Vomiting | 1999 |
Glutaminergic vagal afferents may mediate both retching and gastric adaptive relaxation in dogs.
Topics: Action Potentials; Animals; Catheterization; Dizocilpine Maleate; Dogs; Esophagus; Excitatory Amino Acid Antagonists; Ganglionic Blockers; Glutamic Acid; Hexamethonium; Neurons, Afferent; Quinoxalines; Reflex; Solitary Nucleus; Stomach; Vagotomy; Vagus Nerve; Vomiting | 2001 |
Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Exploratory Behavior; Ferrets; Imidazoles; Male; Ondansetron; Quinoxalines; Receptors, Amino Acid; Receptors, Cell Surface; Serotonin Antagonists; Vomiting | 1992 |
Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion.
Topics: Adult; Aged; Drug Evaluation; Echinomycin; Female; Humans; Infusions, Intravenous; Liver Function Tests; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Quinoxalines; Thrombocytopenia; Vomiting | 1989 |